Product Images Palonosetron

NDC 67184-0515-1 is an injection of Palonosetron HCI manufactured by Qilu Pharmaceutical (Hainan) Co., Ltd. The injection is intended for intravenous use only in a 15mL single-dose sterile vial. The drug must be protected from light and stored at a temperature of 20°C to 25°C (68°F to 77°F). Unused portions must be discarded. The distorted text at the end is not available due to being illegible.*

This appears to be a product label for Palonosetron HCI Injection, including dosage information and the manufacturer's details. There is also some text that is not recognizable by and is hence unreadable.*

This is a product label for Palonosetron HCI Injection, which is intended for intravenous use only. The injection contains 0.25 mg/5 mL (0.5 mg/mL) of palonosetron HCI and is packaged as a 5 mL single-dose sterile vial. Any unused product must be discarded. The label also provides storage instructions to keep the product at a temperature between 20°C and 25°C, protect it from light, and lists the manufacturer, Qiiu Pharmaceutical (Hainan) Co., Ltd., and the distributor, Apotex Corp. The lot number and expiration date are also provided.*

This appears to be a description of a medication called Retain, available in single-dose sterile vials for intravenous injection only. The solution contains palonosetron hydrochloride, sodium citrate, and other ingredients, and is best stored at 20-26°C (68°F-78.8°F). The medication is manufactured by Hainan Oulu Pharmaceutical Co., Ltd in China and distributed in the United States by Apotex Corp. The text also includes instructions to discard unused portions and a cautionary note about excursions in temperature.*